Myron Kaplan, a director at $CRMD, bought 25,000 shares of the company on 10-23-2025 for an estimated $275,500. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 14.2%. Following this trade, they now own 201,034 shares of this class of $CRMD stock.
$CRMD Insider Trading Activity
$CRMD insiders have traded $CRMD stock on the open market 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $CRMD stock by insiders over the last 6 months:
- ELIZABETH HURLBURT (Chief Operating Officer) has made 0 purchases and 2 sales selling 53,997 shares for an estimated $711,817.
- KAUFMAN BETH ZELNICK (Chief Legal Officer) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $670,264.
- JOSEPH TODISCO (Chief Executive Officer) sold 50,000 shares for an estimated $650,000
- MYRON KAPLAN purchased 25,000 shares for an estimated $275,500
- ALAN W DUNTON sold 10,000 shares for an estimated $131,300
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRMD Hedge Fund Activity
We have seen 119 institutional investors add shares of $CRMD stock to their portfolio, and 48 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ELLIOTT INVESTMENT MANAGEMENT L.P. removed 2,444,561 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $30,116,991
- MARSHALL WACE, LLP added 2,349,451 shares (+1019.2%) to their portfolio in Q2 2025, for an estimated $28,945,236
- CITADEL ADVISORS LLC added 1,608,245 shares (+1517.6%) to their portfolio in Q2 2025, for an estimated $19,813,578
- NUVEEN, LLC added 1,194,040 shares (+434.7%) to their portfolio in Q2 2025, for an estimated $14,710,572
- ALYESKA INVESTMENT GROUP, L.P. added 750,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $9,240,000
- GHISALLO CAPITAL MANAGEMENT LLC added 750,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $9,240,000
- ANSON FUNDS MANAGEMENT LP added 725,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $8,932,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRMD Analyst Ratings
Wall Street analysts have issued reports on $CRMD in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 10/21/2025
- D. Boral Capital issued a "Buy" rating on 10/20/2025
- JMP Securities issued a "Market Outperform" rating on 09/09/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/08/2025
- Needham issued a "Buy" rating on 06/24/2025
To track analyst ratings and price targets for $CRMD, check out Quiver Quantitative's $CRMD forecast page.
$CRMD Price Targets
Multiple analysts have issued price targets for $CRMD recently. We have seen 5 analysts offer price targets for $CRMD in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Leonid Timashev from RBC Capital set a target price of $22.0 on 10/21/2025
- Jason Kolbert from D. Boral Capital set a target price of $14.0 on 10/20/2025
- Jason N. Butler from JMP Securities set a target price of $22.0 on 09/09/2025
- Brandon Folkes from HC Wainwright & Co. set a target price of $17.0 on 08/08/2025
- Serge Belanger from Needham set a target price of $20.0 on 06/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
